نتایج جستجو برای: poor water solubility

تعداد نتایج: 788110  

2011
Gurinder Singh Roopa S. Pai Kusum Devi

Solid dispersions traditionally have been used as effective methods to improve the dissolution properties and bioavailability of poorly water-soluble drugs. Furosemide a loop diuretic belonging to Biopharmaceutical Classification System (BCS) Class IV, has very poor water solubility. The aim of the present study was to improve the solubility and dissolution rate of a poorly water-soluble drug, ...

2011
BIRESH SARKAR SWETA TIWARI

Chlordiazepoxide, a member of the 1, 4-benzodiazepine, showing poor aqueous solubility and dissolution rate in water, so the present work was focused to prepare the microspheres of Chlordiazepoxide to improve its solubility and dissolution; using chitosan with different drug: polymer ratio by spray-drying technique. The effect of different drug: polymer ratio on the solubility and dissolution o...

2003
T. BRAILSFORD

It is a truism that ere a tissue or cell can stain in a dye the dye and the elements which stain must first be brought into physical contact. The importance of the solubility of the dye in various tissue elements is evident in this connection and has been especially insisted upon by Witt,’ Georgievic? and A. Fischer.3 Nevertheless as regards the normal protein constituents of cellsaand tissues ...

2012
G. Vijayaranga Vittal R. Deveswaran S. Bharath B. V. Basavaraj V. Madhavan

The present study demonstrates the use of mixed co solvency in the enhancement of solubility and estimation of ketoprofen, practically water insoluble dug and thus precludes the use of organic solvents. The selected solubilizers were sodium citrate (15%), PEG 400 (8%) and polyvinyl pyrolidine (7%). Beer’s law was obeyed in the concentration range of 2-20μg/ml at wavelength of 256nm. The solubil...

2016
Seema Pattewar Sanjay Kasture Vishal Pande Swapnil Sharma

Administration of drug by oral route is the most effective and acceptable route as it has better therapeutic efficacy, low cost and good patient compliance. More than 40% of new drugs are poorly water soluble. These drugs present development challenges and also have poor bioavailability. Although many formulation approaches like solid dispersions, complexation, pH modification exist, novel lipi...

2011
N. S. Sheth

The poor dissolution rate of water-insoluble drugs is still a major problem conforming the pharmaceutical industry. The most common method for improving the solubility is by increasing the surface area of the drug through micronization. But, in practice the effect of micronization is often disappointing, especially when the drugs are encapsulated or tablet. It is generally recognized that low s...

The objectives of present investigations were to optimize concentration of oil, surfactant and cosurfactant by pseudoternary phase diagrams and to develop a stable formulation of self emulsifying drug delivery system (SEDDS) in order to enhance the dissolution rate of poorly soluble Irbesartan (IBS) by SEDDS. Pseudoternary phase diagrams were constructed to identify the self emulsifying region....

2010
Mainak Mookherjee Shun-ichiro Karato

[1] The water solubility in pyrope-rich garnet was determined between pressures of 5–9 GPa and temperatures of 1373– 1473 K under silica activity and oxygen fugacity similar to those expected in the Earth’s upper mantle. We found that pyrope-rich garnet has substantial water solubility up to 0.1 wt% under these conditions. In addition, the water content in garnet varied as a function of chemica...

2011
V Pandit R Gorantla K Devi RS Pai S Sarasija

Pioglitazone, a class II Biopharmaceutical Classification System drug having poor water solubility and slow dissolution rate may have a negative impact on its subtherapeutic plasma drug levels leading to therapeutic failure. In order to improve its water solubility and thus dissolution, cyclodextrin complexation technique was followed. The phase solubility studies were carried using three diffe...

2010
Vandana Patel Hirenkumar Kukadiya Rajshree Mashru Naazneen Surti Surjyanarayan Mandal

Clopidogrel, an inhibitor of platelet aggregation, selectively inhibits the binding of adenosine diphosphate (ADP) to its platelet receptor and the subsequent ADP-mediated activation of the glycoprotein GPIIb/IIIa complex, thereby inhibiting platelet aggregation. Oral bioavailability of clopidogrel is very low (less than 50%), due to its poor water solubility. The aim of this investigation was ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید